FRNRX | GRHAX | FRNRX / GRHAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 30 years | 8 years | - |
Gain YTD | 8.038 | 5.072 | 158% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 338M | 417M | 81% |
Annual Yield % from dividends | 1.83 | 2.93 | 63% |
Returns for 1 year | 16.96 | 4.47 | 379% |
Returns for 3 years | 31.88 | 29.36 | 109% |
Returns for 5 years | 52.42 | 131.18 | 40% |
Returns for 10 years | 22.01 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DILYX | 12.68 | 0.16 | +1.28% |
Davis International Y | |||
FIQKX | 10.29 | 0.06 | +0.59% |
Fidelity Advisor International Value Z | |||
QISGX | 28.61 | 0.11 | +0.39% |
Federated Hermes MDT Small Cap Growth IS | |||
LMGNX | 65.92 | 0.16 | +0.24% |
ClearBridge International Growth I | |||
SHPAX | 19.43 | -0.09 | -0.46% |
Saratoga Health & Biotechnology A |